Recombinant Ab Production
One-stop Solution from Hybridoma Sequencing to Recombinant Antibody
Home > Antibody Services > Recombinant Ab Production
Recombinant Ab Production
With years of research experience and leading expertise in the field of antibody engineering, Synbio Technologies is able to provide a series of recombinant antibody preparation services in diverse forms, including single-chain variable fragment (scFv), antigen-binding fragments (Fab), bispecific antibodies, and chimeric antibody preparation. We provide services for the production of engineered antibodies, from codon optimization; gene synthesis and cloning; and transfection-grade plasmid preparation; to recombinant antibody production in just a few weeks, which facilitates the progress of scientific research projects and drug candidate development.
Highlights
  • Variety of High Expression Vectors
  • Delivery in as Fast as 2 Weeks
  • Ranging from Sequence Design, Vector Construction to Recombinant Antibody Expression and Purification
  • High-Throughput Gene Synthesis and Antibody Expression Platform
  • Cost Effective
Service Details
Services Standard Time Price Deliverables
From Hybridoma Sequencing
to Recombinant Antibody
Hybridoma Sequencing,
Gene Synthesis,
Plasmid Preparation,
Cell Transfection & Cultivation,
Protein Purification,
Antibody Recombination
5-6
Weeks
Starting
at
$1,299
• Expression evaluation with μg-mg antibody
• QC report
Starting
at
$1,599
• ~1 mg antibody
• QC report

* Customers will need to submit hybridoma cell samples (>1×106cells) and indicate the subtype of your monoclonal antibody.

Workflow

FAQs
Resources
Get in Touch with Us
Related Services
  • Address:
    9 Deer Park Dr., Suite J-25
    Monmouth Junction, NJ 08852
  • Tel: +1 732-230-3003
  • Fax: +1 609-228-5911
  • Inquiries: quote@synbio-tech.com

This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you.
To find out more about the cookies we use, see our Privacy Policy.

Accept